Padlock Therapeutics

About:

Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more.

Website: http://padlocktherapeutics.com

Twitter/X: PadlockTx

Top Investors: Index Ventures, Atlas Venture, M Ventures, Johnson & Johnson Development Corporation, Edward Kliphuis

Description:

Padlock is developing medicines targeting protein-arginine deiminases (PADs), enzymes with an important role in the generation of autoantigens, inflammation, and immune complexes in autoimmune diseases. Padlock intends to explore the full biological and therapeutic footprint of protein deimination by PADs. Padlock was founded by scientists at The Scripps Research Institute and members of the Atlas Venture Life Sciences Team. Padlock's investors include Atlas Venture, Johnson & Johnson, and MS Ventures. Padlock is a seed company operating out of the Atlas Venture office in Cambridge MA.